• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血细胞因子作为乳腺癌的肿瘤标志物。乳腺癌患者的 ROC 曲线多变量分析。

Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.

出版信息

Adv Med Sci. 2013;58(2):207-15. doi: 10.2478/ams-2013-0023.

DOI:10.2478/ams-2013-0023
PMID:23846151
Abstract

PURPOSE

Plasma levels of selected hematopoietic cytokines: interleukin 3 ( IL-3), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF), and the tumor marker carcinoma antigen 15-3 (CA 15-3) in breast cancer (BC) patients were investigated and compared to control groups: benign breast tumor patients and healthy subjects.

MATERIAL/METHODS: Cytokine levels were determined by ELISA, CA 15-3 - using the CMIA method.

RESULTS

A significant differences in the concentration of cytokines (with the exception of IL-3) and CA15-3 between the groups of BC patients, benign breast tumor patients and the healthy controls have been demonstrated. M-CSF has demonstrated higher or equal to CA 15-3 values of diagnostic sensitivity, specificity and the predictive values of positive and negative test results. The M-CSF area under the ROC curve (AUC) was the largest from all the cytokines tested and marginally lower than the AUC of CA 15-3.

CONCLUSION

These findings suggest the usefulness of M-CSF in diagnosing breast cancer, especially when discriminating between cancer and non-carcinoma lesions.

摘要

目的

检测并比较乳腺癌(BC)患者与对照组(良性乳腺肿瘤患者和健康受试者)血浆中选定的造血细胞因子(白细胞介素 3 [IL-3]、干细胞因子 [SCF]、粒细胞-巨噬细胞集落刺激因子 [GM-CSF]、粒细胞集落刺激因子 [G-CSF]和巨噬细胞集落刺激因子 [M-CSF])和肿瘤标志物癌抗原 15-3(CA 15-3)的水平。

材料/方法:采用 ELISA 法检测细胞因子水平,采用 CMIA 法检测 CA 15-3。

结果

BC 患者、良性乳腺肿瘤患者和健康对照组之间的细胞因子(除 IL-3 外)和 CA15-3 浓度存在显著差异。M-CSF 的诊断灵敏度、特异性和阳性及阴性预测值均高于或等于 CA 15-3。在所有检测的细胞因子中,M-CSF 的 ROC 曲线下面积(AUC)最大,略低于 CA 15-3 的 AUC。

结论

这些发现表明 M-CSF 可用于诊断乳腺癌,尤其是在区分癌症和非癌性病变方面。

相似文献

1
Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.造血细胞因子作为乳腺癌的肿瘤标志物。乳腺癌患者的 ROC 曲线多变量分析。
Adv Med Sci. 2013;58(2):207-15. doi: 10.2478/ams-2013-0023.
2
[The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].[粒细胞集落刺激因子(G-CSF)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)在Ⅰ、Ⅱ期乳腺癌患者中的血浆水平及诊断效用]
Przegl Lek. 2009;66(7):365-9.
3
[The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].[乳腺癌患者中特定造血生长因子(HGFs)的血浆水平及诊断效用]
Przegl Lek. 2010;67(12):1314-8.
4
VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.血管内皮生长因子、巨噬细胞集落刺激因子和CA 15-3作为乳腺恶性肿瘤新的肿瘤标志物组合:一项采用ROC曲线的多变量分析
Growth Factors. 2013 Jun;31(3):98-105. doi: 10.3109/08977194.2013.797900. Epub 2013 May 21.
5
[The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].[乳腺癌患者血浆中粒细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子的水平]
Pol Merkur Lekarski. 2007 Oct;23(136):259-63.
6
The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.M-CSF在良性乳腺肿瘤和乳腺癌患者中的预处理血浆水平及诊断效用。
Clin Chim Acta. 2006 Sep;371(1-2):112-6. doi: 10.1016/j.cca.2006.02.033. Epub 2006 Apr 21.
7
Hematopoietic cytokines as tumor markers in gynecological malignancies: a multivariate analysis with ROC curve in endometrial cancer patients.造血细胞因子作为妇科恶性肿瘤的肿瘤标志物:子宫内膜癌患者的ROC曲线多变量分析
Growth Factors. 2012 Feb;30(1):29-36. doi: 10.3109/08977194.2011.627332. Epub 2011 Oct 19.
8
Hematopoietic cytokines in the sera of patients with pancreatic cancer.胰腺癌患者血清中的造血细胞因子。
Clin Chem Lab Med. 2005;43(2):146-50. doi: 10.1515/CCLM.2005.024.
9
Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer.造血细胞因子 SCF、IL-3、GM-CSF 和 M-CSF 在胰腺和壶腹癌诊断中的作用。
Int J Biol Markers. 2012 Oct 8;27(3):e186-94. doi: 10.5301/JBM.2012.9348.
10
Hematopoietic growth factors in colorectal cancer patients.结直肠癌患者中的造血生长因子。
Clin Chem Lab Med. 2003 May;41(5):646-51. doi: 10.1515/CCLM.2003.098.

引用本文的文献

1
BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436.BET 靶向 PROTACs 在三阴性乳腺癌细胞系 MDA-MB-231 和 MDA-MB-436 中的作用。
Breast Cancer Res Treat. 2024 Nov;208(1):89-101. doi: 10.1007/s10549-024-07403-w. Epub 2024 Jun 19.
2
Altered gut microbiome drives heightened pain sensitivity in a murine model of metastatic triple-negative breast cancer.肠道微生物群改变驱动转移性三阴性乳腺癌小鼠模型的疼痛敏感性增强。
Am J Cancer Res. 2024 Jan 15;14(1):274-299. doi: 10.62347/LUJF9626. eCollection 2024.
3
Diagnostic Value of Nonacid Nucleic Blood Tumor Marker Panels in Early Diagnosing Breast Cancer: A Systematic Review and Network Meta-Analysis.
非酸性核酸血液肿瘤标志物联合检测对早期诊断乳腺癌的诊断价值:系统评价和网络荟萃分析。
Dis Markers. 2022 Feb 3;2022:4119345. doi: 10.1155/2022/4119345. eCollection 2022.
4
Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients.新辅助治疗的胃肠道癌患者脾脏和外周血免疫恢复情况
Int Immunopharmacol. 2022 May;106:108628. doi: 10.1016/j.intimp.2022.108628. Epub 2022 Feb 21.
5
Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints.粒细胞集落刺激因子在乳腺癌中的表达及其与碳酸酐酶IX和免疫检查点的关联
Cancers (Basel). 2021 Mar 1;13(5):1022. doi: 10.3390/cancers13051022.
6
Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis.人脾髓源抑制性细胞:表型和聚类分析。
Cell Immunol. 2021 May;363:104317. doi: 10.1016/j.cellimm.2021.104317. Epub 2021 Mar 1.
7
The role of granulocyte colony‑stimulating factor in breast cancer development: A review.粒细胞集落刺激因子在乳腺癌发展中的作用:综述。
Mol Med Rep. 2020 May;21(5):2019-2029. doi: 10.3892/mmr.2020.11017. Epub 2020 Mar 10.
8
The Epithelial-Myeloid-Transition (EMyeT) of cancer cells as a wrongly perceived primary inflammatory process eventually progressing to a bone remodeling malignancy: the alternative pathway for Epithelial- Mesenchymal-Transition hypothesis (EMT)?癌细胞的上皮-髓样转化(EMyeT)作为一种被错误认知的原发性炎症过程,最终发展为骨重塑恶性肿瘤:上皮-间质转化假说(EMT)的替代途径?
J Cancer. 2019 Jun 9;10(16):3798-3809. doi: 10.7150/jca.31364. eCollection 2019.
9
Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.在实验室诊断和鉴别选择的宫颈癌组织学类型中,M-CSF 和 VEGF 的血浆水平。
BMC Cancer. 2019 Apr 29;19(1):398. doi: 10.1186/s12885-019-5558-8.
10
Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.血管内皮生长因子(VEGF)、基质金属蛋白酶-9(MMP-9)和基质金属蛋白酶组织抑制因子-1(TIMP-1)的血浆水平及其在乳腺癌患者诊断中的应用价值
Onco Targets Ther. 2016 Feb 24;9:911-9. doi: 10.2147/OTT.S99959. eCollection 2016.